SI3236950T1 - Farmacevtski sestavek, ki obsega kandesartan ali njegove farmacevtsko sprejemljive soli ali estre in amlodipin ali njegove farmacevtsko sprejemljive soli - Google Patents

Farmacevtski sestavek, ki obsega kandesartan ali njegove farmacevtsko sprejemljive soli ali estre in amlodipin ali njegove farmacevtsko sprejemljive soli

Info

Publication number
SI3236950T1
SI3236950T1 SI201531923T SI201531923T SI3236950T1 SI 3236950 T1 SI3236950 T1 SI 3236950T1 SI 201531923 T SI201531923 T SI 201531923T SI 201531923 T SI201531923 T SI 201531923T SI 3236950 T1 SI3236950 T1 SI 3236950T1
Authority
SI
Slovenia
Prior art keywords
pharmaceutically acceptable
acceptable salts
candesartan
amlodipine
esters
Prior art date
Application number
SI201531923T
Other languages
English (en)
Inventor
Tamara German
Tomaz Kapele
Klemen Korasa
Sandra Urek-Blatnik
Franc Vrecer
Original Assignee
Krka, D.D., Novo Mesto
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Krka, D.D., Novo Mesto filed Critical Krka, D.D., Novo Mesto
Publication of SI3236950T1 publication Critical patent/SI3236950T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
SI201531923T 2014-12-24 2015-12-24 Farmacevtski sestavek, ki obsega kandesartan ali njegove farmacevtsko sprejemljive soli ali estre in amlodipin ali njegove farmacevtsko sprejemljive soli SI3236950T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SI201400455 2014-12-24
EP15817391.4A EP3236950B1 (en) 2014-12-24 2015-12-24 Pharmaceutical composition comprising candesartan or pharmaceutically acceptable salts or esters thereof and amlodipine or pharmaceutically acceptable salts thereof
PCT/EP2015/081234 WO2016102705A1 (en) 2014-12-24 2015-12-24 Pharmaceutical composition comprising candesartan or pharmaceutically acceptable salts or esters thereof and amlodipine or pharmaceutically acceptable salts thereof

Publications (1)

Publication Number Publication Date
SI3236950T1 true SI3236950T1 (sl) 2023-04-28

Family

ID=55027757

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201531923T SI3236950T1 (sl) 2014-12-24 2015-12-24 Farmacevtski sestavek, ki obsega kandesartan ali njegove farmacevtsko sprejemljive soli ali estre in amlodipin ali njegove farmacevtsko sprejemljive soli

Country Status (3)

Country Link
EP (1) EP3236950B1 (sl)
SI (1) SI3236950T1 (sl)
WO (1) WO2016102705A1 (sl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022132067A1 (en) * 2020-12-18 2022-06-23 Santa Farma Ilac Sanayii A.S. Stable bilayer tablet compositions
WO2023285646A1 (en) * 2021-07-15 2023-01-19 Adamed Pharma S.A A pharmaceutical composition comprising amlodipine, candesartan cilexetil and hydrochlorothiazide for the treatment of hypertension

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100888131B1 (ko) * 2006-10-10 2009-03-11 한올제약주식회사 시간차 투약 원리를 이용한 심혈관계 질환 치료용 복합제제
EP2106789A1 (en) * 2008-03-31 2009-10-07 KRKA, tovarna zdravil, d.d., Novo mesto Pharmaceutical composition comprising candesartan
PL236001B1 (pl) * 2012-12-21 2020-11-30 Adamed Spolka Z Ograniczona Odpowiedzialnoscia Złożona kompozycja farmaceutyczna zawierająca kandesartan cyleksetylu oraz amlodypinę, sposób jej wytwarzania oraz jednostkowa postać dawkowania zawierająca tę kompozycję

Also Published As

Publication number Publication date
EP3236950B1 (en) 2022-11-23
EP3236950A1 (en) 2017-11-01
WO2016102705A1 (en) 2016-06-30

Similar Documents

Publication Publication Date Title
HK1249103B (zh) 多環氨甲醯基吡啶酮化合物及其藥物用途
HK1244000B (zh) 多環氨基甲酰吡啶酮化合物及其藥物用途
IL247127B (en) Pharmaceutical preparations containing an antipsychotic drug and a vmat2 suppressor and uses thereof
HK1245086A1 (zh) 處方藥物組成及其製備和使用
ZA201703398B (en) Pharmaceutical composition and methods
HK1245085A1 (zh) 處方藥物組成及其製備和使用
PT3202759T (pt) Derivado de alfa-aminoamida e composição farmacêutica contendo o mesmo
HK1245113A1 (zh) 藥物組合物及其用途
PL3145508T3 (pl) Nanocząstki klewidypiny i ich kompozycje farmaceutyczne
HK1232211A1 (zh) 二甲基吡啶胺衍生物及其醫藥用途
IL248854A0 (en) R-pyralindole and its pharmaceutically acceptable salts for use in medicine
GB201406172D0 (en) Therapy and pharmaceutical composition
HK1214767A1 (zh) 片劑形式的藥物組合物及其製造方法
ZA201703015B (en) Solid pharmaceutical composition comprising amlodipine and losartan
SI3236950T1 (sl) Farmacevtski sestavek, ki obsega kandesartan ali njegove farmacevtsko sprejemljive soli ali estre in amlodipin ali njegove farmacevtsko sprejemljive soli
ZA201607353B (en) Bicyclic derivatives and pharmaceutical composition including the same
HK1232144A1 (zh) 經口給藥用醫藥組合物